AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hof, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hof, H

 Previous Article

Antimicrob Agents Chemother. 1989 March; 33(3): 404-405

Antibacterial activities of the antiparasitic drugs nifurtimox and benznidazole.

H Hof

Institute of Medical Microbiology and Hygiene, University of Heidelberg, Faculty of Clinical Medicine Mannheim, Federal Republic of Germany.

ABSTRACT

Both nifurtimox and benznidazole, which are used for the treatment of Chagas' disease, also display marked antibacterial activities. Characteristically for nitroheterocyclic compounds, they are much more active against anaerobic and microaerophilic bacteria than against aerobic bacteria. Nitroreductase-deficient aerobes are completely resistant, whereas SOS-repair-deficient strains are moderately susceptible. Those strains are rapidly killed.

Antimicrob Agents Chemother. 1989 March; 33(3): 404-405






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 1989 by the American Society for Microbiology. All rights reserved.